Colonis launches orange flavour gabapentin after 'palatability issues'

Sponsored

Colonis Pharma has launched epilepsy and neuropathic pain medicine gabapentin in an orange flavour.

The new flavour of Gabapentin Colonis 50mg/ml comes after “a number” of requests to manufacture an alternative to the original aniseed flavour, which has been available since 2012, Colonis said.

The manufacturer launched the orange flavour “to address palatability issues” children had experienced “arising from the aniseed” version.

The orange flavour "gives customers greater choice" and is a "straightforward alternative for pharmacists", Colonis continued.

Gabapentin can be used as an adjunctive therapy to treat epilepsy in adults and children aged six and above; or as a monotherapy in patients over 12, Colonis said.

It can also treat peripheral neuropathic pain – such as painful diabetic neuropathy and post-herpetic neuralgia – in adults, it added.

For more information, contact 01256 316 525

0 Comments
Question: 
How often did you dispense Gabapentin?
Log in or register to post comments

Job of the week

Pharmacist Manager
Ilminster, Somerset
Competitive with incentives
Normal datacapture modal